Arkolith/Insider Trading/SION/Form 4

OrbiMed Capital GP VIII LLC

DirectorSionna Therapeutics, Inc. (SION) · full profile →Form 4 · filed Feb 4, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.4M
Net Open-Market Flow
-$1.4M
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 3, 2026Sell(S)29K$44.58$1.3M3.5M
Feb 2, 2026Sell(S)2K$44.57$84K3.6M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000947871-26-000088) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML